Journal of Critical and Intensive Care
2020 , Vol 11 (Supplement)
Antiviral Agents
1Cukurova University Faculty of Medicine, Chest Disease and ICU, Turkey
DOI :
10.37678/dcybd.2020.2380
Coronavirus disease 2019 (COVID-19) is a respiratory track infection which caused a pandemia after being
recognized in Wuhan, China at the end of 2019. While most people with COVID-19 develop mild or
uncomplicated illness, approximately 14 % develop severe disase requiring hospitalization and oxygen support
and 5 % require intensive care unit admission. Currently, there is no proven reliable and effective antiviral
agent for COVID-19 pneumonia however, more than 100 randomised controlled clinical trials are ongoing.
This paper will discuss the antiviral treatments in the critically ill patients with COVID-19 pneumonia.
Keywords :
COVID-19, pneumonia, antiviral agents, critically ill